NCT01532232 Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix) Status TERMINATED Phase N/A
NCT01531322 A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT01530542 A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01530529 A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999 Status COMPLETED Phase PHASE1
NCT01529671 A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee Status COMPLETED Phase PHASE1
NCT01529346 Efficacy Of PF-05089771 In Treating Postoperative Dental Pain Status COMPLETED Phase PHASE2
NCT01528709 Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial) Status COMPLETED Phase PHASE3
NCT01526057 A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) Status COMPLETED Phase PHASE2
NCT01525550 A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors Status COMPLETED Phase PHASE4
NCT01522989 PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies Status UNKNOWN Phase PHASE1
NCT01522807 A Study Of Three PF-05190457 Formulations In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01521897 Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan) Status COMPLETED Phase N/A
NCT01521884 Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy Status COMPLETED Phase N/A
NCT01520870 Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT. Status COMPLETED Phase PHASE2
NCT01519089 A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis Status COMPLETED Phase PHASE3
NCT01517373 Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin Status COMPLETED Phase PHASE2
NCT01515722 Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder Status COMPLETED Phase NA
NCT01513928 A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects Status COMPLETED Phase PHASE1